1. Home
  2. Live Updates
  3. இந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்

Page 4 - இந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் Today - Breaking & Trending Today

What Is Happening to India's COVID-19 Vaccine Program? - Carnegie India - Carnegie Endowment for International Peace

What Is Happening to India's COVID-19 Vaccine Program? - Carnegie India - Carnegie Endowment for International Peace
carnegieindia.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from carnegieindia.org Daily Mail and Mail on Sunday newspapers.

Andhra Pradesh , United States , United Kingdom , Tamil Nadu , Vinodk Paul , Zydus Cadila , Narendra Modi , Aurobindo Pharma , Arjun Kang Joseph , Aarogya Setu , Joe Biden , Indian Department Of Biotechnology , World Health Organization Emergency Use Listing , Ministry Of Health , Vaccine Alliance , Russian Direct Investment Fund , Carnegie Endowment For International Peace India , Society Program , Serum Institute Of India , Ministry Of External Affairs , Drug Administration , India Central Drugs Standard Control Organisation , Bharatiya Janata Party , Department Of Biotechnology , World Economic Forum Davos Dialogue , Supreme Court ,

Modi-BoJo virtual summit: SII to make vaccine in Britain


Modi-BoJo virtual summit: SII to make vaccine in Britain
New Delhi
Pune-based Serum Institute of India’s plans to manufacture vaccines in the UK was conveyed to PM Modi by none other than the his British counterpart Boris Johnson at the India-UK virtual summit on Tuesday.
Headed by chief executive officer Adar Poonawala, the SII is the world’s largest vaccine maker by volume, and has led in producing the lower-cost AstraZeneca coronavirus shot. The institute makes 60-70 million doses a month, and is aiming for 100 million doses by July.
Johnson’s Downing Street office said the £240 million ($334 million) project would include a sales office, “clinical trials, research and development and possibly manufacturing of vaccines”. ....

United Kingdom , New Delhi , Arindam Bagchi , Sandeep Chakravarty , Aadar Poonawala , Vijay Mallay , Adar Poonawala , Boris Johnson , India Central Drugs Standard Control Organisation , Indian Pharmacopoeia Commission , Serum Institute Of India , Regulatory Agency , Serum Institute , India United Kingdom , Downing Street , Europe West , Kingdom Prime Minister Johnson , Pharmacopoeial Cooperation , British Pharmacopoeia , Central Drugs Standard Control , Nirav Modi , ஒன்றுபட்டது கிஂக்டம் , புதியது டெல்ஹி , அரிந்தம் பாகி , சந்தீப் சக்ரவர்த்தி , ஆதார் பூனாவள ,

Serum Institute submitted its three-month Phase II/III immunogenicity


By Reynald Castaneda
27 Apr 2021
(Last Updated April 27th, 2021 09:43)
Serum Institute of India has provided the three-month data of its Phase II/III trial investigating its Covid-19 vaccine Covishield (SII-ChAdOx1 nCoV-19) to India’s Central Drugs Standard Control Organisation (CDSCO), a spokesperson said.
The first cohort of 400 participants are in the trial’s immunogenicity group, where 300 volunteers received Covishield, and the other 100 volunteers received Vaxzevria. Credits: LookerStudio/Shutterstock.com.
Share Article
Serum Institute of India has provided the three-month data of its Phase II/III trial investigating its Covid-19 vaccine Covishield (SII-ChAdOx1 nCoV-19) to India’s Central Drugs Standard Control Organisation (CDSCO), a spokesperson said. The data pertains to Covishield immunogenicity compared with University of Oxford/AstraZeneca’s Vaxzevria ....

Reynald Castaneda , Covishield Sii Chadox , Serum Institute , India Central Drugs Standard Control Organisation , Serum Institute Of India , Central Drugs Standard Control Organisation , சீரம் நிறுவனம் , இந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , சீரம் நிறுவனம் ஆஃப் இந்தியா , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் ,

Editorial: Time to get vax drive back on track


Send
The government has finally given the green signal to vaccinate all individuals over 18 years of age, from May 1 onward.
File photo
Chennai:
The development comes on the back of India reporting over 2.59 lakh new cases on Tuesday, and 1,761 deaths over the past 24 hours, setting grim new benchmarks in single-day spikes since the beginning of the pandemic. The Centre’s plan to liberalise its vaccination drive has come as a respite of sorts for citizens as states, private hospitals, as well as industrial establishments and corporates, will now be able to directly procure the vaccine doses from the manufacturers.
According to experts, the decision to carry out universal vaccination will lead to significant improvements in the availability of vaccines by July – buoyed by the ramping of production in domestic facilities as well as the arrival of foreign vaccines. NITI Aayog member Dr. Vinod Paul had remarked that inter ....

Tamil Nadu , Vinod Paul , Adar Poonawalla , National Vaccine Strategy Phase , India Central Drugs Standard Control Organisation , Serum Institute Of India , Central Drugs Standard Control Organisation , National Vaccine Strategy , Serum Institute , தமிழ் நாடு , வினோத் பால் , அடார் பூனாவல்ல , இந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , சீரம் நிறுவனம் ஆஃப் இந்தியா , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , தேசிய தடுப்பூசி மூலோபாயம் , சீரம் நிறுவனம் ,

RDIF awaiting SEC recommendation for Sputnik approval in India

RDIF awaiting SEC recommendation for Sputnik approval in India
daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , New Delhi , Republic Of , Sanjeev Sharma , India Central Drugs Standard Control Organisation , Central Drugs Standard Control Organization , Expert Committee , Russian Direct Investment Fund , Subject Expert Committee , Central Drugs Standard Control Organisation , United Kingdom Based , Latin America , Middle East , North Africa , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , புதியது டெல்ஹி , குடியரசு ஆஃப் , சஞ்சீவ் ஷர்மா , இந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் , நிபுணர் குழு , ரஷ்ய நேரடி முதலீடு நிதி , பொருள் நிபுணர் குழு , ஒன்றுபட்டது கிஂக்டம் அடிப்படையிலானது ,